Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)

Completed · Phase 1

Conditions studied: Idiopathic Juxtafoveal Telangiectasia

In brief

This study is a phase 1, open label, non-randomized, multi-center, pilot study to evaluate the safety and tolerability of NT-501 implants in 5-7 study participants with Mactel.

Key facts

Study ID

NCT01327911

Run by

Neurotech Pharmaceuticals

People needed

7

Starts

2011-05-01

Expected to finish

2016-09-01

Last updated by the study team

2016-11-22

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The participant must be offered sufficient opportunity to review the informed consent form, agree to the form's contents and sign the protocol's informed consent;
• The participant must have bilateral MacTel;
• Women of childbearing potential and all men must agree to use an effective form of birth control during the study;
• Participant must be medically able to undergo ophthalmic surgery for ECT implant;
• The participant's best-corrected visual acuity 64 letters or better (20/50 or better) in the study eye;

You may not qualify if…

• Participant is < 21 years of age;
• Participant is medically unable to comply with study procedures or follow- up visits;
• Participant has evidence of ocular disease other than MacTel that may confound the outcome of the study (e.g., diabetic retinopathy with manifest macular edema, uveitis, etc.);
• Participant has a chronic requirement (e.g., ≥ 4 weeks at a time) for ocular medications and/or has a diagnosed disease, that in the judgment of the examining physician, may be vision threatening or may affect the primary outcome (artificial tears are permitted);
• Participant has evidence of subretinal neovascularization in either eye;
• Participant has evidence of central serous chorio-retinopathy (CSR) in either eye;
• Participant has evidence of pathologic myopia in either eye;
• Participant has had a vitrectomy, penetrating keratoplasty, trabeculectomy or trabeculoplasty;

Where it is running

• Jules Stein Eye Institute — Los Angeles, California, United States
• Retina Associates of Cleveland — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.